Free Trial

Pulmatrix (PULM) Competitors

Pulmatrix logo
$6.79 -0.21 (-2.94%)
As of 07/3/2025 01:28 PM Eastern
This is a fair market value price provided by Polygon.io. Learn more.

PULM vs. ATNFW, LBPSW, AEHAW, AIMDW, ALVOW, ARAV, ACABW, BFRIW, BTMDW, and BCTXW

Should you be buying Pulmatrix stock or one of its competitors? The main competitors of Pulmatrix include 180 Life Sciences (ATNFW), 4D pharma (LBPSW), Aesther Healthcare Acquisition (AEHAW), Ainos (AIMDW), Alvotech (ALVOW), ARAVIVE (ARAV), Atlantic Coastal Acquisition Corp. II (ACABW), Biofrontera (BFRIW), biote (BTMDW), and BriaCell Therapeutics (BCTXW). These companies are all part of the "pharmaceutical products" industry.

Pulmatrix vs. Its Competitors

Pulmatrix (NASDAQ:PULM) and 180 Life Sciences (NASDAQ:ATNFW) are both medical companies, but which is the superior investment? We will compare the two companies based on the strength of their profitability, earnings, valuation, media sentiment, analyst recommendations, risk, institutional ownership and dividends.

In the previous week, Pulmatrix's average media sentiment score of 0.00 equaled 180 Life Sciences'average media sentiment score.

Company Overall Sentiment
Pulmatrix Neutral
180 Life Sciences Neutral

180 Life Sciences has lower revenue, but higher earnings than Pulmatrix.

CompanyGross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings Ratio
Pulmatrix$7.81MN/A-$6.94M-$3.34-2.03
180 Life SciencesN/AN/AN/AN/AN/A

180 Life Sciences has a net margin of 0.00% compared to Pulmatrix's net margin of -122.46%. 180 Life Sciences' return on equity of 0.00% beat Pulmatrix's return on equity.

Company Net Margins Return on Equity Return on Assets
Pulmatrix-122.46% -94.97% -84.57%
180 Life Sciences N/A N/A N/A

11.8% of Pulmatrix shares are owned by institutional investors. 0.6% of Pulmatrix shares are owned by company insiders. Strong institutional ownership is an indication that hedge funds, endowments and large money managers believe a stock will outperform the market over the long term.

Summary

Pulmatrix and 180 Life Sciences tied by winning 3 of the 6 factors compared between the two stocks.

Get Pulmatrix News Delivered to You Automatically

Sign up to receive the latest news and ratings for PULM and its competitors with MarketBeat's FREE daily newsletter.

Media Sentiment Over Time

This chart shows the average media sentiment of NASDAQ and its competitors over the past 90 days as caculated by MarketBeat. The averaged score is equivalent to the following: Very Negative Sentiment <= -1.5, Negative Sentiment > -1.5 and <= -0.5, Neutral Sentiment > -0.5 and < 0.5, Positive Sentiment >= 0.5 and < 1.5, and Very Positive Sentiment >= 1.5.
Skip Chart

PULM vs. The Competition

MetricPulmatrixMED IndustryMedical SectorNASDAQ Exchange
Market CapN/A$2.91B$5.53B$8.95B
Dividend YieldN/A2.42%5.38%4.09%
P/E Ratio-2.0321.5627.4020.24
Price / SalesN/A277.33417.66125.07
Price / CashN/A41.9536.6357.47
Price / Book2.777.518.085.67
Net Income-$6.94M-$55.05M$3.16B$248.47M
7 Day Performance-1.54%4.59%2.81%3.29%
1 Month Performance-25.18%4.86%3.69%5.18%
1 Year Performance210.23%5.82%35.30%21.35%

Pulmatrix Competitors List

CompanyMarketRankShare PriceAnalysts' Price Target1Y Price PerformanceMarket CapRevenueP/E RatioEmployee CountIndicator(s)
PULM
Pulmatrix
N/A$6.79
-2.9%
N/A+210.2%$0.00$7.81M-2.0320
ATNFW
180 Life Sciences
N/A$0.01
-4.8%
N/A-19.8%$0.00N/A0.007Positive News
Gap Down
LBPSW
4D pharma
N/AN/AN/AN/A$0.00$522K0.00N/A
AEHAW
Aesther Healthcare Acquisition
N/A$0.01
flat
N/AN/A$0.00N/A0.002
AIMDW
Ainos
N/A$0.15
flat
N/AN/A$0.00$106.21K0.0040Positive News
Gap Up
ALVOW
Alvotech
N/A$1.70
+13.3%
N/A-47.3%$0.00$585.60M0.004Positive News
ARAV
ARAVIVE
N/A$0.04
flat
N/AN/A$0.00$9.14M0.0020High Trading Volume
ACABW
Atlantic Coastal Acquisition Corp. II
N/A$0.02
-0.5%
N/A-74.1%$0.00N/A0.0015
BFRIW
Biofrontera
N/A$0.11
+16.9%
N/A+175.9%$0.00$38.00M0.0070Positive News
Gap Up
BTMDW
biote
N/A$0.01
-31.5%
N/AN/A$0.00$199.38M0.00N/AGap Up
BCTXW
BriaCell Therapeutics
N/A$0.08
+0.1%
N/A-70.4%$0.00N/A0.008Gap Down

Related Companies and Tools


This page (NASDAQ:PULM) was last updated on 7/4/2025 by MarketBeat.com Staff
From Our Partners